SBRA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Sabra Health Care REIT Inc (SBRA) is not a strong buy for a beginner, long-term investor at this moment. While the stock shows some positive long-term potential with analysts raising price targets and a bullish moving average trend, the company's recent financial performance, negative technical indicators, and lack of significant positive catalysts suggest waiting for a better entry point.
The MACD is negative and expanding (-0.0361), indicating bearish momentum. RSI is neutral at 41.47, and the stock is trading below its pivot level of 20.163, with key support at 19.657. While moving averages are bullish (SMA_5 > SMA_20 > SMA_200), the overall technical sentiment leans neutral to bearish.
Analysts have raised price targets, with some maintaining Buy ratings. The senior housing sector within the REIT space is viewed favorably by analysts, and the company's investment yield spread has improved.
The company's Q4 financials show a significant drop in net income (-41.70% YoY) and EPS (-42.11% YoY). Gross margin also declined by 8.17%. Technical indicators suggest bearish momentum, and the stock has a 70% chance of declining in the next week (-9.73%). No recent news or congress trading data is available to act as a positive catalyst.
In Q4 2025, revenue increased by 16.21% YoY to $211.9M. However, net income dropped significantly by 41.70% YoY to $27.23M, and EPS fell by 42.11% YoY to 0.11. Gross margin also declined by 8.17% to 63.75%.
Analysts have raised price targets, with the highest being $24 (Citi). Ratings range from Buy to Neutral, with a cautious outlook on skilled nursing facilities and a preference for senior housing within the REIT space.
